Hallenplan X
MyOrganizer X
Aussteller & Produkte 2008: Ausstellerdatenblatt
MyOrganizer Status
Sie sind momentan nicht angemeldet.
Mit fügen Sie Einträge hinzu.
  Anmelden
Hallenplan
Interaktiver Flash Hallenplan
Vircell S.L.


News Produkte Termine
Basisdaten Firmenprofil Marken Hallenplan
AUSSTELLER Hallenplan
Hallenlageplan anzeigen
Aussteller der MEDICA 2008 Vircell S.L.
Halle 3 / E72  Hallenlageplan anzeigen

Pol. Ind. Dos de Octubre, Plaza Dominguez Ortiz 1
18320 Santa Fe / Granada
Spanien

Telefon: +34 958 441264
Fax: +34 958 510712
http://www.vircell.com

Hersteller Hersteller


Firmenprofil

Company Description

VIRCELL is a biotechnology company, founded in 1991 by clinic microbiologists, dedicated to the production of kits for the diagnosis of uncommon infectious and emergent diseases using different techniques.

We are well known by our unique ready-to-use presentations in Cell Culture, our IFA Multitests kits for pneumonia detection, a wide range of ELISA kits, as well as Brucellacapt®, our own development for the diagnosis of the chronic phase of Brucellosis.
Our company is ISO 9001:2000 certified and all our IVD products are CE marked. We are introduced in most of European countries, in Middle East, Asia and America.

We are proud to say that our company dedicates its biggest efforts in R+D works. Vircell is involved in a non-stopping evolution, coming up with new products. The five main R&D lines of the company are:

-Detection of microbial antigens.
-Production of recombinant antigens.
-Rapid tests.
-Line Blot test.
-PCR ELISA.


Firmendaten
Anzahl der Beschäftigten 20-49
Umsatz 1-9 Mio US $
Exportanteil max. 50%
Gründungsjahr 1991
Geschäftsfelder Physiotherapie / Orthopädietechnik / Krankenhausgymnastik

Kontaktpersonen
Abteilung/Name Adresse

Produktinformationen
  Aussteller der MEDICA 2008 03.02.07  Immun-Assay-Systeme
 
BRUCELLACAPT®
06.11.2008

Description

The high variety of clinical manifestations of the human brucellosis makes difficult the diagnosis. Direct agglutination, Rose Bengal test, Coombs test and ELISA are the most widely used techniques for the serologic diagnosis of brucellosis. While in acute forms, all these techniques are sensitive enough, only the Coombs test can be used in more evolved forms to discard serologically a brucellosis diagnosis. Besides, the increase of titers in serum as measured by the Coombs test may indicate a reactivation of the disease. In this test, incomplete non-agglutinating antibodies are detected by adding, after a washing step that removes immunoglobulins not specific for Brucella, an anti-human immunoglobulin serum that aids the reaction to take place. Yet, since it is tiresome to perform, it is not carried out routinely in many laboratories, leading to a considerable number of not diagnosed cases.
BRUCELLACAPT® is performed in an easy and direct way.
A good correlation has been attained between titers in the Coombs test and in the BRUCELLACAPT®, thus showing a great sensitivity and specificity.

  Aussteller der MEDICA 2008 03.02.07.06  Enzymimmunoassay (EIA, ELISA, EMIT)
  Aussteller der MEDICA 2008 03.04.07  Virenkulturen
  Aussteller der MEDICA 2008 03.05.01  Bakteriologie (Infektionsimmunologie)
  Aussteller der MEDICA 2008 03.05.05  Mikrobiologische Diagnostik/Virologie, Geräte und Systeme für die
  Aussteller der MEDICA 2008 03.05.05.01  Diagnostika / Kits für die mikrobiologische Diagnostik
Seite drucken